Exposure of newborn rats to hyperoxia impairs alveolarization and vessel growth, causing abnormal lung structure that persists during infancy. Recent studies have shown that impaired angiogenesis due to inhibition of vascular endothelial growth factor (VEGF) signaling decreases alveolar and vessel growth in the developing lung, and that nitric oxide (NO) mediates VEGFdependent angiogenesis. The purpose of this study was to determine whether hyperoxia causes sustained reduction of lung VEGF, VEGF receptor, or endothelial NO synthase (eNOS) expression during recovery, and whether inhaled NO improves lung structure in infant rats after neonatal exposure to hyperoxia. Newborn rat pups were randomized to hyperoxia [fraction of inspired oxygen (FiO 2 ), 1.00] or room air exposure for 6 d, and then placed in room air with or without inhaled NO (10 ppm) for 2 wk. Rats were then killed for studies, which included measurements of body weight, lung weight, right ventricular hypertrophy (RVH), morphometric analysis of alveolarization (by mean linear intercept (MLI), radial alveolar counts (RAC), and vascular volume (Vv), and immunostaining and Western blot analysis. In comparison with controls, neonatal hyperoxia reduced body weight, increased MLI, and reduced RAC in infant rats. Lung VEGF, VEGFR-2, and eNOS protein expression were reduced after hyperoxia. Inhaled NO treatment after hyperoxia increased body weight and improved distal lung growth, as demonstrated by increased RAC and Vv and decreased MLI. We conclude that neonatal hyperoxia reduced lung VEGF expression, which persisted during recovery in room air, and that inhaled NO restored distal lung growth in infant rats after neonatal hyperoxia. BPD is the chronic lung disease of infancy that follows ventilator and oxygen therapy for acute respiratory failure after premature birth (1). Traditionally, BPD has been defined by the presence of persistent respiratory signs and symptoms, the need for supplemental oxygen to treat hypoxemia, and an abnormal chest radiograph at 36 wk corrected age. Over the years, the clinical course of premature infants with BPD has changed, reflecting the effects of improved survival of babies who are less mature and have lower birth weights, as well as changes in therapeutic strategies, such as surfactant therapy and modes of mechanical ventilation (2,3). Infants with BPD now have less severe initial acute respiratory disease, and at autopsy, lung histology is predominantly characterized by arrested lung development, including impaired alveolar and vascular growth (4).Although mechanisms that impair lung growth in BPD are poorly understood, recent studies suggest that disruption of VEGF function plays a pivotal role in the pathogenesis of BPD. Bhatt et al. (5) have shown decreased lung VEGF mRNA and protein expression, as well as a reduction of the VEGF receptor, flt-1 (VEGFR-1), in the lungs of infants with fatal BPD. In addition, VEGF protein levels are reduced in the tracheal aspirates obtained from premature newborns with BPD, as well a...